Prev Arrow Stocks

Centene Corporation ($CNC) Stock Forecast: Up 10.4% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Centene Corporation?

Centene Corporation (NYSE: CNC) is a managed care firm that operates in the Medicaid, Medicare, and Marketplace segments. The company focuses on program integrity, risk adjustment, and optimizing its balance sheet.

Why is Centene Corporation going up?

CNC stock is up 10.4% on Apr 29, 2026 16:51

  • Centene Corporation (CNC) witnessed a significant bullish movement today.
  • The uptrend is believed to be a result of the company's impressive Q1 2026 earnings, surpassing expectations and leading to an upward revision of its full-year EPS forecast.
  • Positive reactions from analysts and commendations from firms like Cantor Fitzgerald, who point out a clearer route to margin enhancement, also bolstered the stock's climb.
  • Investor sentiment appears buoyant due to Centene's effective management of medical expenses, enhancements in operations, and robust performance across its primary sectors.

CNC Price Chart

CNC Technical Analysis

CNC News

Stock Of The Day: Where Will The Centene Rally End?

The Centene (NYSE:CNC) stock rally highlights the market principle that "markets have memories," where important price levels retain significance as either resistance or support over extended periods. The stock has demonstrated repeated resistance at $74 and consistent support around $26. Looking ahead, the article suggests potential resistance at $53.25, a prior support level where regretful investors might trigger sell orders.

https://www.benzinga.com/trading-ideas/technicals/26/04/52131750/stock-of-the-day-where-will-the-centene-rally-end

0 News Article Image Stock Of The Day: Where Will The Centene Rally End?

Centene Corporation (NYSE:CNC) Q1 2026 Earnings Call Transcript

Centene Corporation reported strong Q1 2026 adjusted diluted EPS of $3.37, exceeding expectations and leading to an increased full-year EPS outlook of greater than $3.40. The company saw solid performance across its Medicaid, Medicare, and Marketplace segments, driven by operational improvements and strategic management of medical costs and trends. Centene also highlighted its focus on program integrity, management of risk adjustment in the Marketplace, and ongoing efforts to optimize its balance sheet.

https://www.insidermonkey.com/blog/centene-corporation-nysecnc-q1-2026-earnings-call-transcript-1749940/

1 News Article Image Centene Corporation (NYSE:CNC) Q1 2026 Earnings Call Transcript

Centene Corporation (CNC): David Einhorn Is Bullish on This Managed Care Firm

Centene Corporation (NYSE:CNC) is a favorite of David Einhorn, ranking first among his under-the-radar picks. The company recently exceeded Q1 2026 institutional expectations with an Adjusted EPS of $3.37 and $49.94 billion in revenue, leading to an increased full-year guidance. Hedge funds view Centene's performance and improved Health Benefits Ratio as a positive sign, particularly given its defensive government contracts and debt reduction efforts, despite broader industry challenges like Medicaid redetermination headwinds.

https://www.insidermonkey.com/blog/centene-corporation-cnc-david-einhorn-is-bullish-on-this-managed-care-firm-1749612/

2 News Article Image Centene Corporation (CNC): David Einhorn Is Bullish on This Managed Care Firm

Fiverr shares soar 10% on revenue beat, raised profit outlook

Fiverr International Ltd. (NYSE:FVRR) shares surged over 10% in pre-market trading after the company reported first-quarter results that surpassed revenue expectations and increased its full-year adjusted EBITDA guidance. Despite a slight year-over-year revenue decline, Fiverr highlighted strong growth in higher-value projects and expanded its adjusted EBITDA margins. The company raised its full-year adjusted EBITDA outlook while reiterating its revenue guidance and noted a strategic shift towards higher-value engagements, reflected in increased annual spend per buyer.

https://www.investing.com/news/earnings/fiverr-shares-soar-10-on-revenue-beat-raised-profit-outlook-93CH-4643816

3 Missing News Article Image Fiverr shares soar 10% on revenue beat, raised profit outlook

Cantor Fitzgerald upgrades Centene stock rating on margin outlook

Cantor Fitzgerald upgraded Centene Corp. (NYSE:CNC) to Overweight from Neutral and increased its price target to $60 from $41, citing a clearer path to margin improvement based on the company's 2026 guidance. The stock surged 27% in the past week, reflecting investor confidence. Centene's recent Q1 2026 earnings also surpassed analyst expectations, leading Mizuho to raise its price target while maintaining a Neutral rating.

https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-upgrades-centene-stock-rating-on-margin-outlook-93CH-4643744

4 Missing News Article Image Cantor Fitzgerald upgrades Centene stock rating on margin outlook

Centene Corporation Price History

01.03.2026 - CNC Stock was up 5.7%

  • Centene Corporation (CNC) is a diversified healthcare company that provides programs and services to government-sponsored healthcare programs. Today, CNC experienced a strong bullish movement in the market.
  • The bullish movement in CNC stock could be attributed to the positive sentiment in the healthcare sector following the strong performance of companies like UnitedHealth Group (UNH) and Elevance Health (ELV).
  • The current market trend could be influenced by a recent analysis suggesting UnitedHealth Group might face a significant audit exposure, indirectly boosting CNC and emphasizing strength in the industry.
  • Investor confidence in the healthcare sector, including CNC, may have been supported by a notable increase in stake in Elevance Health coupled with their positive Q4 earnings and FY 2026 guidance.
  • The overall stability and growth potential of various healthcare companies, such as HCA Healthcare Inc., likely added to the positive market sentiment, further driving CNC's bullish movement.

02.03.2026 - CNC Stock was up 5.2%

  • CNC experienced a strong bullish movement today.
  • The significant increase in stakes by HF Advisory Group LLC and Rockland Trust Co. in Elevance Health (ELV) could have positively impacted CNC's stock price, as ELV's strong financial performance and raised dividend likely boosted investor confidence in the healthcare sector.
  • Leerink's report on UnitedHealth Group (UNH) facing substantial RADV audit exposure might have indirectly benefited CNC, as investors may have shifted their focus towards other healthcare companies with potentially lower audit risks.
  • Overall, the positive sentiment surrounding healthcare stocks, driven by strong financial results and strategic investments, likely contributed to CNC's bullish market movement today.

16.03.2026 - CNC Stock was up 5.0%

  • CNC is a leading manufacturer of precision tools and equipment for woodworking and metalworking industries. The company has been expanding its product line and market presence, driving strong investor interest.
  • An announcement of a cash dividend payout by MetroCity Bankshares could have positively impacted CNC's stock, indicating a healthy financial market environment.
  • The AI arms race in the healthcare sector causing prior authorization issues and reimbursement cuts may have indirectly boosted CNC's stock as investors seek alternative industries for growth.
  • A price target adjustment on HCA Healthcare by Baird could have led investors to reallocate funds to CNC, viewing it as a more promising investment opportunity.
  • Assetmark Inc.'s increased stake in Elevance Health might have signaled confidence in the healthcare sector, indirectly benefiting CNC as part of a broader market sentiment shift.

29.03.2026 - CNC Stock was up 16.7%

  • Centene's Q1 2026 adjusted diluted EPS of $3.37 surpassed estimates, resulting in an increased full-year EPS forecast, indicating robust operational enhancements and effective cost management.
  • Analyst upgrades from Cantor Fitzgerald and Mizuho, coupled with favorable investor sentiment, boosted the stock's performance, showcasing belief in Centene's margin growth and overall execution.
  • Emphasis on program integrity, risk adjustment oversight, and balance sheet efficiency demonstrated Centene's dedication to sustainable expansion, meeting market expectations and driving the positive momentum in the stock.

29.03.2026 - CNC Stock was up 10.4%

  • Centene Corporation (CNC) witnessed a significant bullish movement today.
  • The uptrend is believed to be a result of the company's impressive Q1 2026 earnings, surpassing expectations and leading to an upward revision of its full-year EPS forecast.
  • Positive reactions from analysts and commendations from firms like Cantor Fitzgerald, who point out a clearer route to margin enhancement, also bolstered the stock's climb.
  • Investor sentiment appears buoyant due to Centene's effective management of medical expenses, enhancements in operations, and robust performance across its primary sectors.

23.03.2026 - CNC Stock was up 5.0%

  • CNC, alongside Molina Healthcare and other managed care companies, experienced a notable increase in their stock prices, suggesting a sector-wide upturn in healthcare plan providers.
  • This surge in CNC's stock was driven by general investor optimism towards the healthcare industry, rather than any company-specific developments.
  • The favorable performance of CNC could be linked to the overall positive outlook on managed care stocks and the healthcare sector at large.
  • It is advisable for investors to closely track CNC's progress and watch for any potential new drivers that could sustain or further enhance its recent gains.

28.03.2026 - CNC Stock was up 5.8%

  • Centene (CNC) delivered outstanding Q1 earnings, posting a non-GAAP EPS of $3.37, significantly ahead of expectations. This impressive performance bolstered investor confidence and led to a bullish trajectory in the stock price.
  • The company generated $49.94 billion in revenue, marking a 7.1% increase compared to the previous year. Additionally, the revised guidance for the year 2026 contributed to a favorable outlook among investors.
  • Analysts responded positively, with firms such as Jefferies and BofA slightly raising their price targets, reflecting optimism in Centene's current performance and future potential.
  • The surge in Centene's stock price can be attributed to the strong earnings report, adjusted guidance, and favorable investor sentiment following strategic moves like debt repayment.

28.03.2026 - CNC Stock was up 15.3%

  • CNC stock surged over 12% today, reflecting a strong bullish movement.
  • The favorable regulatory developments for Centene, such as the approval of 2027 Medicare Advantage and Part D policies with a 2.48% payment rate increase, contributed to the positive market movement. This boosted revenue visibility and reduced regulatory risk.
  • Centene increased its profit outlook for 2026 by implementing tighter control over medical expenses and surpassing analyst expectations in Q1 2026 results. This led to higher investor confidence in the company's strategic initiatives and financial outlook.
  • Investors are optimistic about Centene's cost management efficiency and growth prospects in the healthcare sector, evident in the market's positive reaction.

28.03.2026 - CNC Stock was up 12.8%

  • CNC experienced a strong bullish movement following its Q1 2026 earnings report, which exceeded expectations across the board.
  • The company's adjusted EPS of $3.37 and revenue of $49.94 billion surpassed analyst forecasts, leading to a positive investor sentiment and a stock price increase of over 6% in pre-market trading.
  • CNC's strong performance was driven by Medicaid expansion in Texas and improved operational efficiency across its segments, reflecting the company's strategic initiatives and financial outlook.
  • Analysts responded to the earnings beat by raising price targets, indicating confidence in Centene's continued growth trajectory and market position in the healthcare sector.

26.02.2026 - CNC Stock was up 5.1%

  • CNC witnessed a notable uptick in its stock price today, potentially reflecting investor confidence in the company's operational resilience and diversification strategy in light of industry challenges.
  • The recent 3.00% decline in CNC shares on March 25 appears to be a temporary market response, as financial analysts remain positive with an average target price of $45.71, suggesting considerable growth potential.
  • The forthcoming April 25 earnings release is pivotal for CNC, with investors keenly observing how the company addresses rising Medicaid expenses and changes in its membership profile, seeking indications of financial stability and strategic direction in government healthcare.

23.02.2026 - CNC Stock was down 5.1%

  • CNC stock faced a bearish movement possibly due to analyst pressure amid healthcare sector headwinds and mixed forecasts, leading to a cautious "Hold" consensus.
  • The increased scrutiny on Acadia Healthcare Co, a competitor in the behavioral health sector, due to a US Justice Department probe may have raised concerns about regulatory risks in the industry, impacting CNC's stock valuation.
  • The comparison between UnitedHealth Group (UNH) and CNC, with UNH being highlighted for its consistent growth and profitability, might have also influenced investors to shift towards more stable options in the healthcare sector.
  • The overall uncertainty in the healthcare industry, coupled with Centene's specific challenges such as Medicaid reimbursement issues and rising medical costs, could have contributed to the bearish movement in CNC stock today.

24.02.2026 - CNC Stock was down 5.6%

  • The bearish movement in CNC's stock could be influenced by the overall mixed market sentiment towards healthcare companies and regulatory pressures.
  • The positive earnings report from Jabil Inc. and the subsequent sector-wide rally might have shifted investor focus away from CNC, impacting its stock performance negatively.
  • CNC might also be facing specific challenges or concerns within the healthcare sector, leading to a reevaluation of its prospects by investors.
  • While CNC's performance today was bearish, it could present a potential buying opportunity for investors looking to capitalize on any short-term market fluctuations in the healthcare industry.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.